Neon Health

Overview

Neon Health (legal entity: Belay, Inc.) is an early-stage, AI-first patient access platform targeting the specialty pharmaceutical hub-services market. The company’s core premise is that the traditional hub model — heavily reliant on call center agents, case managers, and manual workflows — is operationally obsolete and can be replaced, at meaningful scale, by a workforce of AI agents. Neon’s software automates the end-to-end patient access stack: benefit verification (BV), prior authorization (PA), copay and patient assistance program (PAP) enrollment, provider referrals, adverse event intake, patient onboarding, and adherence support.

As of its September 2025 funding announcement, Neon was working with approximately six pharmaceutical brands and claimed 1.92 million+ human hours saved across its client base, ROI-positive within eight weeks of deployment, and full payback within three months.

Founding Team

CEO & Co-founder: Stedman Blake Hood — Serial technology entrepreneur with Y Combinator pedigree (PlateJoy, YC S2015). Previously bootstrapped and sold Retriever (lead-generation, acquired ~2021), built Dispatch (Slack productivity tool), and 3x’d demand at Triplebyte. BA Economics (First Class Honours), McGill. No disclosed pharma-services operating experience — his background is firmly in Silicon Valley technology ventures.

CTO & Co-founder: Harry Bleyan — Computational neuroscientist (MIT BSc, 2012-2017), ML engineer at Tesla (ML Infrastructure) and Google (Everyday Robots project). Formal CTO start at Neon: April 2024.

Note on “ex-Lash Group leadership” framing: Public records do not confirm any direct Lash Group or Cencora alumni on Neon’s founding team. Competitive insight comes from market research and customer discovery, not insider operator experience. This is a meaningful distinction: Neon’s perspective is that of an AI-native challenger.

Services & Capabilities

Business Model

Neon sells an AI-powered automation layer that sits on top of existing hub infrastructure, operating as a B2B technology partnership sold to pharma manufacturers, specialty hubs (such as CareMetx), and health systems. Rather than operating as a traditional hub (owning patient relationships, maintaining a call center), Neon “can augment hub operations, embedding into existing processes rather than competing with the hub’s core function.” Positioning: “strategic partner, not a product” — high-touch, consultative implementation with recurring fees tied to automation volume.

Technology Architecture

Capability Module	Function
Voice AI	End-to-end phone call automation with payers; up to 99% of calls with zero human intervention
IVR/Phone Tree Navigation	AI navigates phone systems, waits on hold, patches in hub agent or completes autonomously
Web Portal Automation	Navigates payer and pharmacy portals for eligibility, PA forms, approval status
SMS Automation	Outbound patient engagement for enrollment, refills, barrier identification
Rules Engine	Enterprise-grade workflow orchestration with configurable exception logic
Data Cleaning & Enrichment	Proprietary database of 10M+ data points to clean messy patient/eligibility data
Predictive Scheduling	Optimizes outbound call timing for fastest resolution
Human-in-the-Loop (HITL)	Automatic escalation of complex exceptions; AI retrains on escalation data
QA & Audit Layer	100% quality control coverage via sentiment analysis, structured data extraction, custom quality metrics; full call transcripts

Neon describes this as Level 3-4 conversational AI — agents that reason, navigate multi-turn payer conversations, and handle the full call lifecycle.

Published Performance (CareMetx Case Study)

Metric	Result
ROI	300% within 3 months ($4 saved per $1 spent)
Labor cost reduction	70% per BV (full automation)
Call center throughput	2x (same volume with half the human agents)
On-time delivery	100% (completed annual re-verification one month early)
AI call handling rate	Up to 99% with zero human intervention
Human hours saved (company-wide)	1.92 million+ (per homepage, March 2026)
Tokens processed	100 billion+ (per CTO LinkedIn, October 2025)

Competitive Position

Neon occupies a Tier 3 / emerging AI-native position in the hub services market. Its go-to-market is nuanced — it positions as a technology layer that augments existing hub vendors rather than competing for hub contracts directly.

vs. Traditional Hubs (CareMetx, Lash Group, ConnectiveRx): ~80% cost reduction vs. FTE-heavy models, 2x faster therapy initiation, 100% QA coverage. Can scale instantaneously without hiring cycles. Lacks the scale, client relationships, and full-service capabilities of established hubs.

vs. Infinitus Systems (closest AI competitor, $102.9M raised): Infinitus focuses primarily on voice AI for payer calls with far greater scale (6M+ calls, 100M+ minutes). Neon differentiates by covering the full end-to-end specialty drug patient access workflow (not just payer calls) and by embedding into hub operations rather than selling a horizontal platform.

vs. SuperDial: Different buyer persona — SuperDial serves providers and RCM; Neon serves pharma manufacturers and hub partners.

Key strategic insight: Neon’s CareMetx relationship — where CareMetx COO Brent Barber is the marquee customer testimonial — indicates the primary near-term strategy is selling into hubs as a workflow automation vendor. Lower-friction GTM than displacing hub contracts, creating a land-and-expand dynamic: automate BV first, then PA, then adherence, then full case management.

Recent Developments

September 2025 — $6M Seed Round. NFX led with DigiTx Partners (Astellas Pharma/MPM Capital JV), Olive Capital, Ascend Venture Capital, Village Global, Digital Health Venture Partners. Confirmed six pharma brand clients. DigiTx’s involvement provides pharma-strategic investor with industry relationships.

October 2025 — 100 Billion Token Milestone. CTO Harry Bleyan disclosed surpassing 100 billion tokens processed — signal of real production workload.

October 2025 — Patient Support Summit Case Study. First industry conference appearance. Detailed CareMetx deployment: 300% ROI, 70% cost reduction, 2x throughput.

Q1 2026 — Metric Acceleration. Homepage metrics grew from 424,760+ to 1.92M+ human hours saved between late 2025 and March 2026 — roughly 4.5x increase implying rapid client ramp or new brand launches.

Ongoing — Brand Consolidation. Legal entity (Belay, Inc.) and previous Tensor brand consolidated under Neon Health identity.

Financial Profile

Metric	Detail
Total funding	$6M (seed, September 2025)
Lead investor	NFX (James Currier, GP)
Revenue	Not disclosed; Wellfound notes “7-figure customer contracts” and claims profitable
Employees	15-30
Ownership	VC-backed; founders retain significant equity
Valuation	Not disclosed

Operated from January 2023 to September 2025 without disclosed external funding, suggesting bootstrapped/founder-funded origins. The “7+ figure customer contracts” claim achieved within four months of founding — if accurate, implies ARR in the $1-9.9M range.

Sources

• Neon Health website, Seed round blog (Sep 2025), Patient Support Summit Case Study PDF, Elion Health, IntuitionLabs Hub Comparison, Wellfound, Harry Bleyan LinkedIn, Market.us Hub Services Report
• Perplexity Wave 2 Agent 17 enrichment (raw/research/07_neon_health.md)